Lupin Ltd has received final approval from the US health regulator for its generic antibiotic minocycline hydrochloride extended-release tablets used for treating acne. The approval by the US Food and Drug Administration (USFDA) has been granted to the company’s subsidiary, Lupin Pharmaceuticals Inc, for tablets of 65 mg, 80 mg, 105 mg and 115 mg strengths. The tablets are generic versions of Medicis Pharmaceutical Corporation’s patented drug Solodyn.
It is an oral antibiotic approved to treat only the red, pus-filled pimples of moderate to severe acne in patients 12 years of age and older. Citing market research firm IMS’ September 2011 data, the company said Solodyn had sales of $750 million.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: